What is the most recent earnings date for TVRD stock?
TVARDI THERAPEUTICS INC (TVRD) last reported earnings on 3/31/2026.
NASDAQ:TVRD • US1407553072
Past quarterly earnings results for TVARDI THERAPEUTICS INC (TVRD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.78 | -0.66 | -18.33% | -302.48% | - | -100.00% | ||
| Q3 2025 | -0.59 | -1.02 | 42.14% | 92.87% | - | -100.00% | ||
| Q2 2025 | -1.00 | -0.58 | -71.45% | 92.49% | - | -100.00% | ||
| Q1 2025 | -3.22 | -0.36 | -801.96% | 84.03% | 2.569M | 1.224M | 109.89% | 20.33% |
| Q4 2024 | -0.19 | - | 99.09% | 1.455M | 1.628M | -10.63% | -51.56% | |
| Q3 2024 | -8.28 | -9.06 | 8.59% | 55.77% | 2.556M | 1.649M | 55.00% | -47.84% |
| Q2 2024 | -13.32 | -10.06 | -32.39% | 36.21% | 991K | 1.197M | -17.21% | -85.64% |
| Q1 2024 | -20.16 | -14.61 | -37.94% | -14.29% | 2.135M | 1.724M | 23.84% | -65.56% |
| Q4 2023 | -21.24 | -15.13 | -40.40% | -5.36% | 3.004M | 9.61M | -68.74% | -8.97% |
| Q3 2023 | -18.72 | -19.09 | 1.96% | -20.93% | 4.9M | 10.15M | -51.72% | -54.63% |
| Q2 2023 | -20.88 | -19.77 | -5.63% | -625.00% | 6.9M | 6.693M | 3.09% | -70.00% |
| Q1 2023 | -17.64 | -19.15 | 7.87% | 5.77% | 6.2M | 5.082M | 22.00% | 29.17% |
| Q4 2022 | -20.16 | -11.75 | -71.57% | 11.11% | 3.3M | 16.576M | -80.09% | 312.50% |
| Q3 2022 | -15.48 | -15.37 | -0.72% | -2,050.00% | 10.8M | 10.027M | 7.71% | -46.80% |
| Q2 2022 | -2.88 | -9.30 | 69.04% | 86.89% | 23M | 21.121M | 8.90% | - |
| Q1 2022 | -18.72 | -19.71 | 5.01% | -10.64% | 4.8M | 3.227M | 48.74% | 152.63% |
| Q4 2021 | -22.68 | -18.94 | -19.77% | -139.62% | 800K | 1.487M | -46.20% | -99.29% |
| Q3 2021 | -0.72 | -14.53 | 95.04% | 94.29% | 20.3M | 11.431M | 77.59% | 118.28% |
| Q2 2021 | -21.96 | -19.57 | -12.23% | -12.96% | 2.645M | -100.00% | -100.00% | |
| Q1 2021 | -16.92 | -21.66 | 21.90% | 24.19% | 1.9M | 2.405M | -21.00% | -76.54% |
| Q4 2020 | 57.24 | 13.38 | 327.91% | - | 112.1M | 49.601M | 126.00% | - |
| Q3 2020 | -12.60 | -21.93 | 42.54% | - | 9.3M | 4.867M | 91.08% | - |
| Q2 2020 | -19.44 | -24.44 | 20.47% | - | 5.6M | 5.158M | 8.57% | - |
| Q1 2020 | -22.32 | -22.72 | 1.76% | - | 8.1M | 4.856M | 66.80% | - |
Notes
TVARDI THERAPEUTICS INC (TVRD) last reported earnings on 3/31/2026.
TVARDI THERAPEUTICS INC (TVRD) missed EPS estimates and missed revenue estimates in the most recent quarter.